We are live on
!
Find out more
KA
Kearns & Associates Portfolio holdings
AUM
$214M
1-Year Est. Return
23.8%
This Fund
S&P 500
This Quarter
Est. Return
+11.25%
1 Year Est. Return
+23.8%
3 Year Est. Return
+69.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$11.2M
(+11%)
Cap. Flow
-$501K
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
88.63%
Holding
45
New
2
Increased
4
Reduced
4
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$525K |
| 2 |
Union Pacific
UNP
|
+$198K |
| 3 |
Danaher
DHR
|
+$194K |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$74.9K |
| 5 |
Schwab International Equity ETF
SCHF
|
+$28.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$380K |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$303K |
| 3 |
UnitedHealth
UNH
|
+$252K |
| 4 |
Charter Communications
CHTR
|
+$220K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$219K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.19% |
| 2 | Financials | 4.14% |
| 3 | Communication Services | 1.61% |
| 4 | Healthcare | 1.25% |
| 5 | Energy | 1.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$935B
| $333K | 0.28% |
1,960
| – | – |
|
27
MetLife
MET
$61.9B
| $331K | 0.28% |
5,000
| – | – |
|
28
Equinix
EQIX
$101B
| $310K | 0.26% |
385
| – | – |
|
29
iShares Core S&P 500 ETF
IVV
$878B
| $289K | 0.25% |
605
| – | – |
|
30
ConocoPhillips
COP
$147B
| $288K | 0.25% |
2,482
| – | – |
|
31
Stryker
SYK
$125B
| $287K | 0.25% |
960
| – | – |
|
32
Capital One
COF
$128B
| $285K | 0.24% |
2,170
| – | – |
|
33
Qualcomm
QCOM
$155B
| $276K | 0.24% |
1,905
-640
| -25% | -$79.3K |
|
34
Walt Disney
DIS
$167B
| $273K | 0.23% |
3,020
| – | – |
|
35
Comcast
CMCSA
$85B
| $263K | 0.22% |
6,000
| – | – |
|
36
Johnson Controls International
JCI
$88.8B
| $259K | 0.22% |
4,500
| – | – |
|
37
Baker Hughes
BKR
$60B
| $256K | 0.22% |
7,500
| – | – |
|
38
Lowe's Companies
LOW
$117B
| $223K | 0.19% |
1,000
| – | – |
|
|
39
Union Pacific
UNP
$174B
| $221K | 0.19% |
+900
| New | +$198K |
|
40
Johnson & Johnson
JNJ
$618B
| $219K | 0.19% |
1,400
| – | – |
|
|
41
Danaher
DHR
$137B
| $211K | 0.18% |
+910
| New | +$194K |
|
42
Cisco
CSCO
$457B
| $202K | 0.17% |
4,000
| – | – |
|
|
43
Bristol-Myers Squibb
BMY
$133B
| – | – |
-3,770
| Closed | -$219K |
|
|
44
Charter Communications
CHTR
$17.3B
| – | – |
-500
| Closed | -$220K |
|
|
45
UnitedHealth
UNH
$376B
| – | – |
-500
| Closed | -$252K |
|
Similar funds
TSS
CMBA
RC
VCM
IH
IAM
CCM
VFG
Kearns & Associates's Q4 2023 Portfolio in Review
As of Q4 2023, Kearns & Associates held 45 positions worth $117M, up 11% from $106M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Kearns & Associates's Q4 2023 filing shows 2 new, 4 increased, 4 reduced and 3 closed positions. Its largest new stake was Union Pacific: 900 shares worth $221K. The largest sale was Vanguard Morningstar Small-Cap ETF, an estimated $380K.
By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 5.1% a quarter earlier, followed by Financials and Communication Services.
- Kearns & Associates's largest Q4 2023 buy was Union Pacific: 900 shares worth $221K.
- Kearns & Associates added most to Vanguard FTSE Developed Markets ETF in Q4 2023, an estimated $525K increase.
- Kearns & Associates's biggest Q4 2023 reduction was Vanguard Morningstar Small-Cap ETF, cutting an estimated $380K.
- Kearns & Associates fully exited UnitedHealth in Q4 2023, selling an estimated $252K.
- Kearns & Associates's ten largest holdings make up 89% of its $117M portfolio in Q4 2023.
- Kearns & Associates opened 2 new positions and closed 3 in Q4 2023.
- Kearns & Associates's portfolio value rose 11% quarter-over-quarter to $117M.
Based on Kearns & Associates's 13F filing for Q4 2023, filed 24 Jan 2024.